116 related articles for article (PubMed ID: 9675133)
1. Cell-specific transfection of choriocarcinoma cells by using Sindbis virus hCG expressing chimeric vector.
Sawai K; Meruelo D
Biochem Biophys Res Commun; 1998 Jul; 248(2):315-23. PubMed ID: 9675133
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
3. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.
Ohno K; Sawai K; Iijima Y; Levin B; Meruelo D
Nat Biotechnol; 1997 Aug; 15(8):763-7. PubMed ID: 9255791
[TBL] [Abstract][Full Text] [Related]
4. Reducing cytotoxicity induced by Sindbis viral vectors.
Sawai K; Ikeda H; Ishizu A; Meruelo D
Mol Genet Metab; 1999 May; 67(1):36-42. PubMed ID: 10329021
[TBL] [Abstract][Full Text] [Related]
5. Properties of Sindbis virus vectors produced with a chimeric split helper system.
Ketola A; Schlesinger S; Wahlfors J
Int J Mol Med; 2005 Jun; 15(6):999-1003. PubMed ID: 15870906
[TBL] [Abstract][Full Text] [Related]
6. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein.
Suzuki S; Shimada T
Biochem Biophys Res Commun; 2000 May; 271(3):672-6. PubMed ID: 10814520
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
[TBL] [Abstract][Full Text] [Related]
8. Short-order Sindbis vector targeting.
Wickham T
Nat Biotechnol; 1997 Aug; 15(8):717. PubMed ID: 9255777
[No Abstract] [Full Text] [Related]
9. Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages.
Sonoda N; Katabuchi H; Tashiro H; Ohba T; Nishimura R; Minegishi T; Okamura H
Placenta; 2005 Apr; 26(4):298-307. PubMed ID: 15823616
[TBL] [Abstract][Full Text] [Related]
10. Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system.
Altman-Hamamdzic S; Groseclose C; Ma JX; Hamamdzic D; Vrindavanam NS; Middaugh LD; Parratto NP; Sallee FR
Gene Ther; 1997 Aug; 4(8):815-22. PubMed ID: 9338010
[TBL] [Abstract][Full Text] [Related]
11. Expression of a recombinant bifunctional protein from a chimera of human lutropin receptor and human chorionic gonadotropin beta-subunit.
Hao M; Rathnam P; Saxena B
J Reprod Immunol; 2004 Oct; 63(2):123-35. PubMed ID: 15380943
[TBL] [Abstract][Full Text] [Related]
12. Controlled propagation of replication-competent Sindbis viral vector using suicide gene strategy.
Tseng JC; Daniels G; Meruelo D
Gene Ther; 2009 Feb; 16(2):291-6. PubMed ID: 18818670
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection.
Morizono K; Xie Y; Ringpis GE; Johnson M; Nassanian H; Lee B; Wu L; Chen IS
Nat Med; 2005 Mar; 11(3):346-52. PubMed ID: 15711560
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization.
González ME; Carrasco L
Virology; 2001 Jan; 279(1):201-9. PubMed ID: 11145902
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
16. Transient low pH treatment enhances infection of lentiviral vector pseudotypes with a targeting Sindbis envelope.
Morizono K; Ringpis GE; Pariente N; Xie Y; Chen IS
Virology; 2006 Nov; 355(1):71-81. PubMed ID: 16905172
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.
Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R
Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645
[TBL] [Abstract][Full Text] [Related]
18. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells.
Pizzato M; Blair ED; Fling M; Kopf J; Tomassetti A; Weiss RA; Takeuchi Y
Gene Ther; 2001 Jul; 8(14):1088-96. PubMed ID: 11526456
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of recombinant alphaviruses as vectors in gene therapy.
Wahlfors JJ; Zullo SA; Loimas S; Nelson DM; Morgan RA
Gene Ther; 2000 Mar; 7(6):472-80. PubMed ID: 10757020
[TBL] [Abstract][Full Text] [Related]
20. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.
Zavorotinskaya T; Albritton LM
Mol Ther; 2001 Mar; 3(3):323-8. PubMed ID: 11273774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
